Construction of a pH-responsive, ultralow-dose triptolide nanomedicine for safe rheumatoid arthritis therapy

Yang Liu,Jianqiu Jin,Hao Xu,Chao Wang,Yanping Yang,Yongjian Zhao,Haihui Han,Tong Hou,Guoliang Yang,Li Zhang,Yongjun Wang,Weian Zhang,Qianqian Liang
DOI: https://doi.org/10.1016/j.actbio.2020.11.027
IF: 10.633
2021-02-01
Acta Biomaterialia
Abstract:<p>Rheumatoid arthritis (RA) is a chronic autoimmune disease, marked by joint swelling and pain, articular synovial hyperplasia, as well as cartilage and bone destruction. Triptolide (TP) is an anti-inflammatory molecule but its use to treat RA is limited due to poor solubility and extremely high toxicity. In this study, by encapsulating TP into a star-shaped amphiphilic block copolymer, POSS-PCL-b-PDMAEMA, we engineered a pH-sensitive TP-loaded nanomedicine () to simultaneously reduce the toxicity of TP and improve its therapeutic efficacy. shows a uniform spherical structure with a hydrodynamic diameter of ∼92 nm and notable pH-responsiveness. <em>In vitro</em> showed reduced cytotoxicity and cell apoptosis of treated RAW264.7 cells compared to free TP. And <em>in vivo</em> intravenous injection of indocyanine green-labeled NPs into a collagen-induced arthritis model in mice showed that the engineered compound had potent pharmacokinetic and pharmacodynamic profiles, while exhibiting significant cartilage-protective and anti-inflammatory effects with a better efficacy and neglible systemic toxicity even at an ultralow dose compared to free TP. These results suggest that may be a safe and effective therapy for RA and other autoimmune diseases.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?